Acuta Capital Erasca Bets Big on Targeted Cancer Therapies
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
This article explains common warning signs that your budget is failing and provides quick steps to assess spending, adjust categories, and regain control.
11,415 articlesA niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
A hypothetical chair kevin warsh $6.7 balance sheet presents a tough puzzle for policy and markets. This article brea...
KeyBanc boosts Okta's target to $103 from $95, citing a brighter security spending outlook and the central role of id...
A global push to deploy AI-ready data centers is boosting capital spending toward a roughly $1 trillion wave that cou...
Standex stock surged 60% in a rapid rally that grabbed attention from institutions and regular investors alike. This ...
Chewy, crowned america’s best brand america’s in a 2026 reputation poll, faces a sharp stock drop as brand strength f...
James Murdoch takes over Vox Media’s New York magazine and podcast network, pledging ambitious journalism and agenda-...
A policy push to cover GLP-1 drugs for weight loss under Medicare stalled, leaving many beneficiaries in the middle. ...
Private markets are tightening their grip on everyday investing. This article explains how the line between public an...
Looking for a meaningful tech stock investment with a modest starting stake? Here is a practical case for Uber as the...
Fairholme trimmed its stake in The St. Joe Company, but that doesn’t mean the stock isn’t worth a closer look. Here’s...
Trump’s Iran ceasefire plan draws fierce GOP skepticism, while financial markets react with oil and equities whipsaws...